Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Zippi applies for you, and finds you a job.
| Fiscal year / year | Delcath Systems revenue |
|---|---|
| 2018 | $3.4M |
| 2019 | $1.6M |
| 2020 | $1.6M |
| 2021 | $3.6M |
| 2022 | $2.7M |
| 2023 | $2.1M |
| 2024 | $37.2M |
How accurately did Delcath Systems' revenue projections match actual performance?
| Year | Delcath Systems growth |
|---|---|
| 2019 | -54%↓ |
| 2020 | 4%↑ |
| 2021 | 116%↑ |
| 2022 | -24%↓ |
| 2023 | -24%↓ |
| 2024 | 1702%↑ |
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2018 | $702,000 | $858,000 | $824,000 | $1.0M |
| 2019 | $270,000 | $412,000 | $380,000 | $518,000 |
| 2020 | $294,000 | $379,000 | $466,000 | $507,000 |
| 2021 | $388,000 | $536,000 | $522,000 | $2.1M |
| 2022 | $378,000 | $797,000 | $906,000 | $639,000 |
| 2023 | $597,000 | $495,000 | $434,000 | $539,000 |
| 2024 | $3.1M | $7.8M | $11.2M | $15.1M |
Do you work at Delcath Systems?
Is Delcath Systems transparent about its revenue structure?
Delcath Systems received early financing of $14.2M on 2007-10-18.
| Series | Round size | Date |
|---|---|---|
| Post Ipo Equity | $14.2M | 10/2007 |
| Post Ipo Debt | $20M | 04/2012 |
| Convertible Note | $35M | 06/2016 |
| Post Ipo Equity | $2M | 07/2017 |
| Post Ipo Equity | $5M | 02/2018 |
| Post Ipo Equity | $20M | 07/2019 |
| Post Ipo Equity | $22.2M | 12/2020 |
| Post Ipo Debt | $20M | 08/2021 |
| Investors | Security type |
|---|---|
| Silicon Valley Bank | Post Ipo Debt |
| Avenue Capital Group | Post Ipo Debt |
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| ADVANCED NEUROMODULATION SYSTEMS INC | - | $100.1M | 750 | - |
| Inamed Corporation | - | - | 20 | - |
| Cepheid | $86,295 | $531.1M | 6,000 | 7 |
| Tigris Pharmaceuticals | $46,428 | $220,000 | 5 | - |
| Aastrom Biosciences | $51,812 | - | - | - |
| NeuroStar | $89,053 | $74.9M | 150 | 1 |
| MAP Pharmaceuticals | $87,034 | $23.1M | 137 | - |
| Nektar Therapeutics | $83,561 | $98.4M | 718 | - |
| Incyte | $103,592 | $4.2B | 1,600 | 39 |
| PerSeptive Biosystems, Inc | $74,665 | - | 605 | - |
Zippia gives an in-depth look into the details of Delcath Systems, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Delcath Systems. The employee data is based on information from people who have self-reported their past or current employments at Delcath Systems. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Delcath Systems. The data presented on this page does not represent the view of Delcath Systems and its employees or that of Zippia.
Delcath Systems may also be known as or be related to DELCATH SYSTEMS INC., DELCATH SYSTEMS, INC., Delcath Systems, Delcath Systems Inc, Delcath Systems, Inc and Delcath Systems, Inc.